Literature DB >> 28097887

Pseudokinases: update on their functions and evaluation as new drug targets.

Dominic P Byrne1, Daniel M Foulkes1, Patrick A Eyers1.   

Abstract

The pseudokinase complement of the human kinase superfamily consists of approximately 60 signaling proteins, which lacks one or more of the amino acids typically required to correctly align ATP and metal ions, and phosphorylate protein substrates. Recent studies in the pseudokinase field have begun to expose the biological relevance of pseudokinases, which are now thought to perform a diverse range of physiological roles and are connected to a multitude of human diseases, including cancer. In this review, we discuss how and why members of the 'pseudokinome' represent important new targets for drug discovery, and describe how knowledge of protein structure and function provides informative clues to help guide the rational chemical design or repurposing of inhibitors to target pseudokinases.

Entities:  

Keywords:  cancer; cysteine; cysteinome; disease; enzyme; inhibitor; kinase; kinome; pseudoenzyme; pseudokinase; signaling

Mesh:

Substances:

Year:  2017        PMID: 28097887     DOI: 10.4155/fmc-2016-0207

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  22 in total

1.  Human pantothenate kinase 4 is a pseudo-pantothenate kinase.

Authors:  Jiangwei Yao; Chitra Subramanian; Charles O Rock; Suzanne Jackowski
Journal:  Protein Sci       Date:  2019-04-17       Impact factor: 6.725

2.  High-Resolution Structure and Inhibition of the Schizophrenia-Linked Pseudokinase ULK4.

Authors:  Susmita Khamrui; Peter M U Ung; Cody Secor; Avner Schlessinger; Michael B Lazarus
Journal:  J Am Chem Soc       Date:  2019-12-17       Impact factor: 15.419

3.  Structural versatility that serves the function of the HRD motif in the catalytic loop of protein tyrosine kinase, Src.

Authors:  Yixin Cui; Gongqin Sun
Journal:  Protein Sci       Date:  2018-12-30       Impact factor: 6.725

4.  FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane.

Authors:  Derek F Ceccarelli; Sofiia Ivantsiv; Amber Anne Mullin; Etienne Coyaud; Noah Manczyk; Pierre Maisonneuve; Igor Kurinov; Liang Zhao; Chris Go; Anne-Claude Gingras; Brian Raught; Sabine Cordes; Frank Sicheri
Journal:  Structure       Date:  2019-05-02       Impact factor: 5.006

5.  Protein AMPylation by an Evolutionarily Conserved Pseudokinase.

Authors:  Anju Sreelatha; Samantha S Yee; Victor A Lopez; Brenden C Park; Lisa N Kinch; Sylwia Pilch; Kelly A Servage; Junmei Zhang; Jenny Jiou; Monika Karasiewicz-Urbańska; Małgorzata Łobocka; Nick V Grishin; Kim Orth; Roza Kucharczyk; Krzysztof Pawłowski; Diana R Tomchick; Vincent S Tagliabracci
Journal:  Cell       Date:  2018-09-27       Impact factor: 41.582

6.  Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cells.

Authors:  Daniel M Foulkes; Dominic P Byrne; Wayland Yeung; Safal Shrestha; Fiona P Bailey; Samantha Ferries; Claire E Eyers; Karen Keeshan; Carrow Wells; David H Drewry; William J Zuercher; Natarajan Kannan; Patrick A Eyers
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 8.192

Review 7.  Integrin Linked Kinase (ILK) and its Role in Liver Pathobiology.

Authors:  Nicole Martucci; George K Michalopoulos; Wendy M Mars
Journal:  Gene Expr       Date:  2021-01-22

8.  Long noncoding RNA TUG1 regulates the progression of colorectal cancer through miR-542-3p/TRIB2 axis and Wnt/β-catenin pathway.

Authors:  Quanlin Liu; Wei Zhang; Linshan Luo; Keshun Han; Ruitao Liu; Shue Wei; Xiaoran Guo
Journal:  Diagn Pathol       Date:  2021-05-24       Impact factor: 2.644

9.  KinCon: Cell-based recording of full-length kinase conformations.

Authors:  Florian Enzler; Philipp Tschaikner; Rainer Schneider; Eduard Stefan
Journal:  IUBMB Life       Date:  2020-02-06       Impact factor: 3.885

10.  A small molecule inhibitor of HER3: a proof-of-concept study.

Authors:  Audrey Colomba; Martina Fitzek; Roger George; Gregory Weitsman; Selene Roberts; Laura Zanetti-Domingues; Michael Hirsch; Daniel J Rolfe; Shahid Mehmood; Andrew Madin; Jeroen Claus; Svend Kjaer; Ambrosius P Snijders; Tony Ng; Marisa Martin-Fernandez; David M Smith; Peter J Parker
Journal:  Biochem J       Date:  2020-09-18       Impact factor: 3.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.